UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Learn effective ways to earn more credit card rewards. Maximize your savings and enjoy additional benefits on every purchase.
27,294 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Two tobacco giants show divergent paths over 10 years, with dividend income boosting returns for both. Here's what ha...
Retirees who start Social Security early and continue working may see withheld benefits restored later. The earnings ...
SpaceX is planning a NASDAQ debut with a monumental valuation, but the pre-IPO materials avoid a central issue: the q...
USD Private unveils a closed digital asset platform featuring a programmed price path from $1 to $1 million over four...
Bitcoin retraced after a volatile stretch, pushing traders to rethink income-focused strategies. This piece breaks do...
Netflix trades below $78 as investors weigh ad-supported growth and margin targets. Analysts dispute whether the stoc...
Investors are turning away from Hewlett Packard Enterprise as a dividend-rich tech giant with a clearer AI roadmap ga...
BlackRock kicked off 2026 with record ETF inflows and a quarterly earnings beat, fueling optimism across markets. The...
As 2026 unfolds, a new government analysis finds that majors tied to real-world demand offer strong pay and job stabi...
Trump Media & Technology Group pivots from traditional media toward a Bitcoin treasury, with 2025 revenue of $3.7 mil...
Zcash slid roughly 15% in 48 hours, pushing toward $230 as a classic reversal pattern took hold and market sentiment ...